[Celecoxib inhibits gastric adenocarcinoma growth via inducing expression of human nonsteroidal anti-inflammatory drug activated gene].

Objective: To investigate the effect of cyclooxygenase2 inhibitor celecoxib on the suppression of human gastric cancer (GC) growth and the induction of nonsteroidal anti-inflammatory drug activated gene (NAG-1) expression.

Methods: Thirty-six GC patients were randomly divided into two groups before curative surgery. Celecoxib group patients (n = 20) took celecoxib orally 0.